Kevin Kotler, 10% Owner at Recro Pharma, Inc. (REPH), sold 76,000 shares at $10.00 ($750K) on 2017-12-20, disclosed to the SEC on 2017-12-22.
Open-market sale of $750k REPH by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $10.00 | 25,000 | $250K | 33.3% |
| 2 | $9.80 | 40,000 | $392K | 52.2% |
| 3 | $9.84 | 11,000 | $108K | 14.4% |
| Total | $9.87 avg | 76,000 | $750K | 100% |
| Filing → |
| BDSI | SELL | 2019-04-15 | $10.0M | — | Filing → |
| NVLN | SELL | 2018-12-27 | $483K | — | Filing → |
| SSKN | SELL | 2016-03-14 | $348K | — | Filing → |